The round was led by Insight Partners, a global venture capital and private equity firm focused on investing in ScaleUp software companies. Existing investors Fulcrum Equity Partners, Bee Partners, and Flashpoint also joined this round. The investment will further Florence's mission of connecting pharmaceutical companies and study sites, paving the way for more decentralized trials and more efficient drug development lifecycles.

Florence is a global leader in remote connectivity and electronic document workflow management for clinical trials. More than 8,500 research sites in 34 countries, sponsors and CROs collaborate on the network. Florence solutions foster 25% faster clinical trial startup time, 40% reduced document cycle times, and enable more than 3 million remote monitoring activities every month. To learn more, visit florencehc.com.